Clinical Trial Update: A Study of Carilizumab Combined With Concurrent Chemoradiotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of Carilizumab with concurrent chemoradiotherapy for cervical cancer is underway with no status information available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Carilizumab (Carilizumab)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN